Social Prescribing Supports Youth Waiting for Mental Health Services

A groundbreaking study from University College London (UCL) sheds new light on the potential of social prescribing to support adolescents awaiting specialist mental health services. As mental health services face unprecedented demand, with over 350,000 young people in England alone on waiting lists averaging almost eight months, innovative interventions are urgently needed. This study, published in European Child & Adolescent Psychiatry, explored how connecting youths with community activities and support resources might buffer against the negative effects of these delays.

The researchers enrolled more than 550 adolescents aged 11 to 18 referred to Child and Adolescent Mental Health Services (CAMHS) across England. Participants who received tailored social prescribing referrals—which included engagement in arts, exercise, and other social activities—exhibited notable improvements in their behavioral health. Key outcomes included reductions in conduct difficulties and enhanced quality of relationships with family and peers. Importantly, these improvements suggest that social prescribing may foster resilience during a vulnerable waiting period.

While the intervention did not significantly affect symptoms of depression, anxiety, or stress within the six-month follow-up, experts underscore that social prescribing is intended as a complement, not a substitute, for formal psychological treatments. Instead, the approach appears to boost day-to-day functioning and strengthens protective psychosocial factors that help young people manage stressors more effectively while they await clinical care.

The study’s lead author, Dr. Daniel Hayes of UCL’s Behavioural Science & Health department, emphasized the real-world relevance: “Our findings highlight how social prescribing supports adolescents in building confidence and problem-solving skills during an often isolating wait for specialist help.” One participant reflected on the intervention’s impact, noting enhanced openness in discussing their feelings with family and educators. Such qualitative feedback underscores the model’s personalized approach, where link workers facilitate connections to interests ranging from karate and art classes to book clubs and nature walks.

Senior author Professor Daisy Fancourt further clarified that social prescribing’s value lies in its role as an empowering, person-centered bridge to treatment. By engaging in meaningful activities, young people can not only enhance their mental resilience but also arrive at specialist services in a more “treatment-ready” state. This approach represents a paradigm shift, turning passive waiting into active preparation.

This research builds upon earlier work from the same team, which demonstrated sizable wellbeing gains among adults—including young people—referred to social prescribing. Utilizing anonymized data from nearly 20,000 individuals, that study identified consistent improvements across mental wellbeing metrics such as happiness, life satisfaction, and anxiety reduction.

Funded by the Prudence Trust and supported by Wellcome and the Economic and Social Research Council, the new UCL study offers compelling evidence that embedding social prescribing within mental health pathways could transform our response to burgeoning demand. Amid long wait times, providing young people with avenues for social connection and personal growth emerges as a critical tool for safeguarding and enhancing mental health resilience.

As healthcare systems worldwide grapple with increasing mental health challenges, this evidence positions social prescribing not simply as a stopgap but as a vital adjunct that bolsters adolescents’ capacity to navigate adversity and thrive.